Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist not yet licensed by the MHRA or EMA
BPC-157, often referred to as the Body Protection Compound , is one of the most widely discussed peptides due to its potential support in areas like: Soft tissue recovery (muscles, tendons, ligaments) Digestive wellness (gut lining, inflammation response) Joint health and mobility Inflammation control for active or aging bodies Its important to note that BPC-157 is not FDA-approved for medical use
Acts as a selective antioxidant, can penetrate deep into cells and support natural regeneration processes
That's the loop GLP-1 users keep coming back for
Reviews (6) Description FAQ Description BPC-157 is commonly referenced in connective tissue biology, gut barrier research, and inflammatory signalling studies